| Predicate |
Object |
| contentType |
Journal Article |
| endingPage |
129 |
| issn |
1535-7511
1535-7597 |
| issueIdentifier |
5 |
| pageRange |
125-129 |
| publicationName |
Epilepsy Currents |
| startingPage |
125 |
| bibliographicCitation |
Krauss GL. Evaluating Risks for Vigabatrin Treatment. Epilepsy Curr. 2009 Sep;9(5):125–9. doi: 10.1111/j.1535-7511.2009.01315.x. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_778a0ee95b2ad23eda3d53beb71e5a49 |
| date |
200909 |
| identifier |
https://pubmed.ncbi.nlm.nih.gov/19826501
https://pubmed.ncbi.nlm.nih.gov/PMC2759040
https://doi.org/10.1111/j.1535-7511.2009.01315.x |
| isPartOf |
https://portal.issn.org/resource/ISSN/1535-7511
https://portal.issn.org/resource/ISSN/1535-7597
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/30364 |
| language |
English |
| source |
https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/ |
| title |
Evaluating Risks for Vigabatrin Treatment |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7617
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7548
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9263
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9603
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5665 |